Abstract
The field of veterinary biologics has been the primary benefactor of the limited number of genetically engineered products. Several recombinant DNA (r-DNA) vaccines used to prevent enterotoxigenic Escherichia coli disease in livestock animals are currently available world-wide (e. g. , EcoBac, and Scourguard) and a vaccine for foot and mouth disease is available in limited markets. In this paper, the author discusses the rationale behind the development of r-DNA vaccines and some of the methods used in their preparation. Discussion of viral-based vaccines is minimal, although not excluded. The details of the processes used to develop an E. coli r-DNA vaccine are used as a primary example.
| Original language | English (US) |
|---|---|
| Title of host publication | Biotechnol, Appl and Res |
| Publisher | Technomic Publ Co |
| Pages | 352-359 |
| Number of pages | 8 |
| ISBN (Print) | 0877623910 |
| State | Published - 1985 |